The Antipyretic Analgesics Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antipyretic Analgesics Market report covers segmental analysis by Type (Acetates, Fenamates, Oxicam, Propionates, Salicylates, Acetoaminophen); Route of Administration (Oral, Intravenous, Topical, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Antipyretic Analgesics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antipyretic Analgesics Market Segmentation
Type- Acetates
- Fenamates
- Oxicam
- Propionates
- Salicylates
- Acetoaminophen
- Oral
- Intravenous
- Topical
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Strategic Insights
Antipyretic Analgesics Market Growth Drivers- Rising Prevalence of Fever and Pain-related Conditions: Rising population and aging of the global population have increased the prevalence of health issues such as fever, headaches, arthritis, and muscular pain, which are being treated with Antipyretic Analgesics. Chronic pain and fever-related disorders are increasing the demand for effective, over-the-counter pain relief solutions, directly driving the growth of the Antipyretic Analgesics Market. Demand for the product in the market and innovation are increased as more and more people in developing regions seek accessible relief.
- Increasing Self-medication and Over-the-counter Drug Utilization: Self-medication has emerged to be one of the most influential driving factors of the Antipyretic Analgesics Market as most of the consumers resort to Over-the-counter OTC pain relief drugs for minor pains, fever, or inflammation without prescription. The wide availability of pharmacies as well as online platforms through which Antipyretic Analgesics have become easily and readily available eases the rise in health awareness. Over-the-counter drugs avail all the merits like convenience, as well as low cost, so these medicines are increasingly turning out to be the choice of patients to treat pain that can be mild and moderate in its intensity.
- Advancements in Antipyretic and Analgesic Formulations: Novel and more effective Antipyretic Analgesics with fewer side effects push the market forward. The new extended-release tablets, combination products, and liquid preparations of both for adults and children have greatly increased the variety of products available. More than that, these innovations enhance the appeal of the market and respond to the growing needs by carefully tailoring solutions to meet specific patient needs in solving pain.
- Combination Products for Enhanced Efficacy: The future promises a grout of combination products by the Antipyretic Analgesics Market. Combination medicines are those containing two or more pharmacologically active moieties that treat both pain and fever at the same time instead of separately with single drugs, thus delivering comfort as well as efficacy while in administration. As consumers are necessarily bound to ask for ever-faster effective treatments, one would anticipate a heightened market influenced by lines of combination products.
- Regulatory Support for Innovative Pain and Fever Treatments: Governments and other regulatory agencies are going to be more supportive of new and novel Antipyretic Analgesics. As public health is the focus, regulations would ease up in terms of new product approvals, especially where the products boast improved safety profiles, reduced side effects, and better therapeutic performance. Easy pathways to approvals and rewards for novel formulations will speed up innovation for the Antipyretic Analgesics Market.
- Telemedicine and Remote Prescription Services: Telemedicine advancement continuously puts pressure on the Antipyretic Analgesics Market. It's quite obvious that COVID-19 has speeded up the process. The online prescriptions and delivery of antipyretic analgesics will have a positive trend in the future as remote health care consultation has become the new normal. Prescriptions and advisory for the Antipyretic Analgesics will be virtually available to the patients by consulting the doctors, who may then conveniently order them through online pharmacies or even have them delivered to their residence. This makes it more convenient and accessible to the customers, mainly for areas which are harder to reach.
- E-commerce and Direct-to-Consumer Sales Channels: Increasing internet penetration along with customer's health purchase such as that of OTC Antipyretic Analgesics, are a direct entry route to reaching customers. Enhanced confidence of buying healthcare products using internet-based media gives a remarkable boost to it. This can be done by fine-tuning the online distribution channel, providing subscription models for regular consumers, and investing in digital marketing strategies that help build brand recognition and loyalty. With the advancement of pharmacogenomics and personalized medicine, there is enormous scope for developing demographic-specific Antipyretic Analgesics.
- Personalized and Tailored Pain Management Solutions: customizing pain-relieving formulations to be specifically prepared from the individual's genetic signature would offer pharma companies access to newer streams of developing even safer and effective Antipyretic Analgesics. As the possibilities arise to take personalized treatment approaches in the context of AI and digital health, a niche space waits for the company, which can market the offering as something designed particularly for health-conscious customers. The change in consumer health needs creates the opportunity for companies in the Antipyretic Analgesics Market to expand adjacent categories in a comprehensive product portfolio.
- Expansion of Product Lines into Adjacent Categories: Businesses will increase sales and establish consumer loyalty when they provide a product bundle or cross-promote these products through the larger health and wellness market. For example, pain relief drug manufacturers can extend their brand penetration by selling anti-inflammatory drugs, cough and cold medicines, or immune-boosting supplements as complementary health products.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antipyretic Analgesics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antipyretic Analgesics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antipyretic Analgesics Market is expected to register a CAGR of 6.8% from 2025-2031.
The major factors impacting the Antipyretic Analgesics Market are: Rising Prevalence of Fever and Pain-related Conditions, Increasing Self-medication and Over-the-counter Drug Utilization and Advancements in Antipyretic and Analgesic Formulations
Key future trends in this market are - Combination Products for Enhanced Efficacy, Regulatory Support for Innovative Pain and Fever Treatments and Telemedicine and Remote Prescription Services
Key companies of this market are: Sun Pharmaceuticals, Johnson and Johnson, Sanofi, Pfizer Inc., GlaxoSmithKline Plc., Cipla Ltd., Teva Pharmaceuticals, Novartis AG, Mylan, Bayer AG
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antipyretic Analgesics Market - By Type
1.3.2 Antipyretic Analgesics Market - By Route of Administration
1.3.3 Antipyretic Analgesics Market - By Distribution Channel
1.3.4 Antipyretic Analgesics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIPYRETIC ANALGESICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIPYRETIC ANALGESICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIPYRETIC ANALGESICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIPYRETIC ANALGESICS - GLOBAL MARKET OVERVIEW
6.2. ANTIPYRETIC ANALGESICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIPYRETIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACETATES
7.3.1. Overview
7.3.2. Acetates Market Forecast and Analysis
7.4. FENAMATES
7.4.1. Overview
7.4.2. Fenamates Market Forecast and Analysis
7.5. OXICAM
7.5.1. Overview
7.5.2. Oxicam Market Forecast and Analysis
7.6. PROPIONATES
7.6.1. Overview
7.6.2. Propionates Market Forecast and Analysis
7.7. SALICYLATES
7.7.1. Overview
7.7.2. Salicylates Market Forecast and Analysis
7.8. ACETOAMINOPHEN
7.8.1. Overview
7.8.2. Acetoaminophen Market Forecast and Analysis
8. ANTIPYRETIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ANTIPYRETIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. ANTIPYRETIC ANALGESICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antipyretic Analgesics Market Overview
10.1.2 North America Antipyretic Analgesics Market Forecasts and Analysis
10.1.3 North America Antipyretic Analgesics Market Forecasts and Analysis - By Type
10.1.4 North America Antipyretic Analgesics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Antipyretic Analgesics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Antipyretic Analgesics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antipyretic Analgesics Market
10.1.6.1.1 United States Antipyretic Analgesics Market by Type
10.1.6.1.2 United States Antipyretic Analgesics Market by Route of Administration
10.1.6.1.3 United States Antipyretic Analgesics Market by Distribution Channel
10.1.6.2 Canada Antipyretic Analgesics Market
10.1.6.2.1 Canada Antipyretic Analgesics Market by Type
10.1.6.2.2 Canada Antipyretic Analgesics Market by Route of Administration
10.1.6.2.3 Canada Antipyretic Analgesics Market by Distribution Channel
10.1.6.3 Mexico Antipyretic Analgesics Market
10.1.6.3.1 Mexico Antipyretic Analgesics Market by Type
10.1.6.3.2 Mexico Antipyretic Analgesics Market by Route of Administration
10.1.6.3.3 Mexico Antipyretic Analgesics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Antipyretic Analgesics Market Overview
10.2.2 Europe Antipyretic Analgesics Market Forecasts and Analysis
10.2.3 Europe Antipyretic Analgesics Market Forecasts and Analysis - By Type
10.2.4 Europe Antipyretic Analgesics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Antipyretic Analgesics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Antipyretic Analgesics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antipyretic Analgesics Market
10.2.6.1.1 Germany Antipyretic Analgesics Market by Type
10.2.6.1.2 Germany Antipyretic Analgesics Market by Route of Administration
10.2.6.1.3 Germany Antipyretic Analgesics Market by Distribution Channel
10.2.6.2 France Antipyretic Analgesics Market
10.2.6.2.1 France Antipyretic Analgesics Market by Type
10.2.6.2.2 France Antipyretic Analgesics Market by Route of Administration
10.2.6.2.3 France Antipyretic Analgesics Market by Distribution Channel
10.2.6.3 Italy Antipyretic Analgesics Market
10.2.6.3.1 Italy Antipyretic Analgesics Market by Type
10.2.6.3.2 Italy Antipyretic Analgesics Market by Route of Administration
10.2.6.3.3 Italy Antipyretic Analgesics Market by Distribution Channel
10.2.6.4 Spain Antipyretic Analgesics Market
10.2.6.4.1 Spain Antipyretic Analgesics Market by Type
10.2.6.4.2 Spain Antipyretic Analgesics Market by Route of Administration
10.2.6.4.3 Spain Antipyretic Analgesics Market by Distribution Channel
10.2.6.5 United Kingdom Antipyretic Analgesics Market
10.2.6.5.1 United Kingdom Antipyretic Analgesics Market by Type
10.2.6.5.2 United Kingdom Antipyretic Analgesics Market by Route of Administration
10.2.6.5.3 United Kingdom Antipyretic Analgesics Market by Distribution Channel
10.2.6.6 Rest of Europe Antipyretic Analgesics Market
10.2.6.6.1 Rest of Europe Antipyretic Analgesics Market by Type
10.2.6.6.2 Rest of Europe Antipyretic Analgesics Market by Route of Administration
10.2.6.6.3 Rest of Europe Antipyretic Analgesics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antipyretic Analgesics Market Overview
10.3.2 Asia-Pacific Antipyretic Analgesics Market Forecasts and Analysis
10.3.3 Asia-Pacific Antipyretic Analgesics Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Antipyretic Analgesics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Antipyretic Analgesics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Antipyretic Analgesics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antipyretic Analgesics Market
10.3.6.1.1 Australia Antipyretic Analgesics Market by Type
10.3.6.1.2 Australia Antipyretic Analgesics Market by Route of Administration
10.3.6.1.3 Australia Antipyretic Analgesics Market by Distribution Channel
10.3.6.2 China Antipyretic Analgesics Market
10.3.6.2.1 China Antipyretic Analgesics Market by Type
10.3.6.2.2 China Antipyretic Analgesics Market by Route of Administration
10.3.6.2.3 China Antipyretic Analgesics Market by Distribution Channel
10.3.6.3 India Antipyretic Analgesics Market
10.3.6.3.1 India Antipyretic Analgesics Market by Type
10.3.6.3.2 India Antipyretic Analgesics Market by Route of Administration
10.3.6.3.3 India Antipyretic Analgesics Market by Distribution Channel
10.3.6.4 Japan Antipyretic Analgesics Market
10.3.6.4.1 Japan Antipyretic Analgesics Market by Type
10.3.6.4.2 Japan Antipyretic Analgesics Market by Route of Administration
10.3.6.4.3 Japan Antipyretic Analgesics Market by Distribution Channel
10.3.6.5 South Korea Antipyretic Analgesics Market
10.3.6.5.1 South Korea Antipyretic Analgesics Market by Type
10.3.6.5.2 South Korea Antipyretic Analgesics Market by Route of Administration
10.3.6.5.3 South Korea Antipyretic Analgesics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Antipyretic Analgesics Market
10.3.6.6.1 Rest of Asia-Pacific Antipyretic Analgesics Market by Type
10.3.6.6.2 Rest of Asia-Pacific Antipyretic Analgesics Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Antipyretic Analgesics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antipyretic Analgesics Market Overview
10.4.2 Middle East and Africa Antipyretic Analgesics Market Forecasts and Analysis
10.4.3 Middle East and Africa Antipyretic Analgesics Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Antipyretic Analgesics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Antipyretic Analgesics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Antipyretic Analgesics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antipyretic Analgesics Market
10.4.6.1.1 South Africa Antipyretic Analgesics Market by Type
10.4.6.1.2 South Africa Antipyretic Analgesics Market by Route of Administration
10.4.6.1.3 South Africa Antipyretic Analgesics Market by Distribution Channel
10.4.6.2 Saudi Arabia Antipyretic Analgesics Market
10.4.6.2.1 Saudi Arabia Antipyretic Analgesics Market by Type
10.4.6.2.2 Saudi Arabia Antipyretic Analgesics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Antipyretic Analgesics Market by Distribution Channel
10.4.6.3 U.A.E Antipyretic Analgesics Market
10.4.6.3.1 U.A.E Antipyretic Analgesics Market by Type
10.4.6.3.2 U.A.E Antipyretic Analgesics Market by Route of Administration
10.4.6.3.3 U.A.E Antipyretic Analgesics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Antipyretic Analgesics Market
10.4.6.4.1 Rest of Middle East and Africa Antipyretic Analgesics Market by Type
10.4.6.4.2 Rest of Middle East and Africa Antipyretic Analgesics Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Antipyretic Analgesics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antipyretic Analgesics Market Overview
10.5.2 South and Central America Antipyretic Analgesics Market Forecasts and Analysis
10.5.3 South and Central America Antipyretic Analgesics Market Forecasts and Analysis - By Type
10.5.4 South and Central America Antipyretic Analgesics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Antipyretic Analgesics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Antipyretic Analgesics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antipyretic Analgesics Market
10.5.6.1.1 Brazil Antipyretic Analgesics Market by Type
10.5.6.1.2 Brazil Antipyretic Analgesics Market by Route of Administration
10.5.6.1.3 Brazil Antipyretic Analgesics Market by Distribution Channel
10.5.6.2 Argentina Antipyretic Analgesics Market
10.5.6.2.1 Argentina Antipyretic Analgesics Market by Type
10.5.6.2.2 Argentina Antipyretic Analgesics Market by Route of Administration
10.5.6.2.3 Argentina Antipyretic Analgesics Market by Distribution Channel
10.5.6.3 Rest of South and Central America Antipyretic Analgesics Market
10.5.6.3.1 Rest of South and Central America Antipyretic Analgesics Market by Type
10.5.6.3.2 Rest of South and Central America Antipyretic Analgesics Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Antipyretic Analgesics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIPYRETIC ANALGESICS MARKET, KEY COMPANY PROFILES
12.1. BAYER AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYLAN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CIPLA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Bayer AG
2. Novartis AG
3. GlaxoSmithKline PLC
4. Pfizer Inc.
5. Johnson and Johnson
6. Sanofi
7. Teva Pharmaceuticals
8. Mylan
9. Cipla
10. Sun Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For